Literature DB >> 7925281

AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes.

M Rincón1, R A Flavell.   

Abstract

The transcription factor AP-1 contributes significantly to the regulation of interleukin-2 gene transcription during T-cell activation and may play a role in thymocyte development. To study the regulation of AP-1 transcriptional activity in primary T-cells, reporter transgenic mice were generated that express luciferase gene under the control of AP-1 binding sites. Here, we demonstrate that while protein kinase C activation is sufficient to induce DNA-binding activity, an additional intracellular calcium increase is required to induce transcriptional activity of AP-1 in primary mouse T-cells. Furthermore, transcriptional, but not DNA-binding, activity of AP-1 is cyclosporin sensitive and requires tyrosine phosphorylation. This dissociation between DNA-binding and transcriptional activity is likely due, at least partially, to post-translational modifications of the AP-1 complex required for transcriptional activity. Moreover, in addition to these two signals delivered by ligand binding to the T-cell receptor (TcR) AP-1 transcriptional activity absolutely requires the presence of a co-stimulatory signal that can be mediated by the interaction of CD28 with its ligands B7-1 and B7-2. Thus, TcR-mediated and co-stimulatory signals required for T-cell activation appear to be integrated, in part, at the level of the regulation of transcriptional activity of AP-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925281      PMCID: PMC395364          DOI: 10.1002/j.1460-2075.1994.tb06757.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

Review 1.  The role of the T3/antigen receptor complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; B Manger; C Terhorst; J Stobo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

2.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

3.  A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation.

Authors:  F Saatcioglu; T Deng; M Karin
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

4.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

5.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

6.  JNK is involved in signal integration during costimulation of T lymphocytes.

Authors:  B Su; E Jacinto; M Hibi; T Kallunki; M Karin; Y Ben-Neriah
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

7.  B70 antigen is a second ligand for CTLA-4 and CD28.

Authors:  M Azuma; D Ito; H Yagita; K Okumura; J H Phillips; L L Lanier; C Somoza
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

8.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.

Authors:  M K Jenkins; R H Schwartz
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.

Authors:  G J Freeman; F Borriello; R J Hodes; H Reiser; J G Gribben; J W Ng; J Kim; J M Goldberg; K Hathcock; G Laszlo
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  87 in total

1.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.

Authors:  E Kopp; R Medzhitov; J Carothers; C Xiao; I Douglas; C A Janeway; S Ghosh
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

Review 2.  Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression.

Authors:  Kartika Padhan; Rajat Varma
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

Review 3.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 4.  Transcriptional reprogramming during T helper cell differentiation.

Authors:  T M Aune
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells.

Authors:  Oliver Dienz; Sheri M Eaton; Troy J Krahl; Sean Diehl; Colette Charland; John Dodge; Susan L Swain; Ralph C Budd; Laura Haynes; Mercedes Rincon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

6.  Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.

Authors:  T D Batiuk; L Kung; P F Halloran
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

7.  Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

8.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

9.  Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.

Authors:  M Rincón; H Enslen; J Raingeaud; M Recht; T Zapton; M S Su; L A Penix; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

10.  Stability of sulforaphane for topical formulation.

Authors:  Stephen J Franklin; Sally E Dickinson; Kelly L Karlage; G T Bowden; Paul B Myrdal
Journal:  Drug Dev Ind Pharm       Date:  2013-04-23       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.